Financial Results SummaryTotal third party revenues for the quarter ended December 31, 2010, increased $82.7 million, or 6%, to $1.43 billion from $1.35 billion in the same prior year period. Total third party revenues include both net revenues and other revenues from third parties. Net revenues increased $89.1 million, or 7%, to $1.42 billion from $1.34 billion in the prior year quarter. The effect of foreign currency translation had an unfavorable impact of approximately 1% on total third party revenues primarily reflecting a weaker Euro in comparison to the US Dollar, partially offset by the strengthening of other currencies, primarily the Indian Rupee, Japanese Yen and Australian Dollar. Translating current year revenues at prior year exchange rates would have resulted in year-over-year growth in net revenues excluding foreign currency of approximately $104 million, or 8%. Other revenues for the quarter ended December 31, 2010, and 2009 were $9.9 and $16.3 million, respectively.
A tabular summary of the Company's revenues for the quarters ended December 31, 2010, and 2009, is included at the end of this release.
Mylan has two segments, "Generics" and "Specialty." Generics third party net sales, which are derived from sales in North America, Europe, the Middle East and Africa (collectively, EMEA) and Asia Pacific were $1.35 billion in the current quarter, compared to $1.28 billion in the same prior year period.
Third party net sales from North America were $647.5 million for the current quarter, compared to $533.4 million for the comparable prior year period, representing an increase of $114.1 million or 21.4%. This increase was mainly driven by new products launched in the U.S. and Canada, which contributed sales of $73.5 million in the current quarter, as well as a full quarter of contri
|SOURCE Mylan Inc.|
Copyright©2010 PR Newswire.
All rights reserved